Dabigatran, a direct thrombin inhibitor, can be a life-saving treatment in heparin-induced thrombocytopenia

<div><p class="abstract"><strong>BACKGROUND:</strong> Several studies have emphasized thrombosis associated with thrombocytopenia as a potentially fatal complication of heparin. A number of agents are used for this condition. As a new oral, reversible direct thrombi...

Full description

Bibliographic Details
Main Author: Ahmad Mirdamadi
Format: Article
Language:English
Published: Vesnu Publications 2013-01-01
Series:ARYA Atherosclerosis
Online Access:http://arya.mui.ac.ir/index.php/arya/article/view/428
_version_ 1818842800188293120
author Ahmad Mirdamadi
author_facet Ahmad Mirdamadi
author_sort Ahmad Mirdamadi
collection DOAJ
description <div><p class="abstract"><strong>BACKGROUND:</strong> Several studies have emphasized thrombosis associated with thrombocytopenia as a potentially fatal complication of heparin. A number of agents are used for this condition. As a new oral, reversible direct thrombin inhibitor, dabigatran has been approved for short-term thromboprophylaxis after elective hip and knee replacement surgery. We present a case of dabigatran administration in a patient with femoral fracture.</p> <p class="abstract"><strong>CASE REPORT:</strong> A 67-year-old woman referred to the orthopedic ward of Shariati Hospital (Isfahan, Iran) due to femoral fracture following an accident. Immediately after surgery, she was found to be suffering from deep vein thrombosis (DVT) in her lower extremity despite sufficient prophylaxis by enoxaparin. Laboratory data showed severe thrombocytopenia. Considering the clinical history, an initial diagnosis of heparin-induced thrombocytopenia was made. Doppler ultrasound confirmed the diagnosis. Heparin was thus replaced with dabigatran which increased platelet count to the normal range and improved DVT.</p> <p class="abstract"><strong>CONCLUSION:</strong> Dabigatran can be a life-saving treatment in heparin-induced thrombocytopenia. However, it is contraindicated in patients with renal dysfunction since it may cause potentially catastrophic results.</p> <p class="abstract">&nbsp;</p></div> <strong>Keywords:</strong> Heparin Induced Thrombocytopenia, Heparin, Enoxaparin, Dabigatran
first_indexed 2024-12-19T04:47:44Z
format Article
id doaj.art-372d330673144995a64e6b7a9ce64564
institution Directory Open Access Journal
issn 1735-3955
2251-6638
language English
last_indexed 2024-12-19T04:47:44Z
publishDate 2013-01-01
publisher Vesnu Publications
record_format Article
series ARYA Atherosclerosis
spelling doaj.art-372d330673144995a64e6b7a9ce645642022-12-21T20:35:25ZengVesnu PublicationsARYA Atherosclerosis1735-39552251-66382013-01-0191112114363Dabigatran, a direct thrombin inhibitor, can be a life-saving treatment in heparin-induced thrombocytopeniaAhmad Mirdamadi0Assistant Professor, Department of Cardiology, School of Medicine, Najafabad Branch, Islamic Azad University, Isfahan, Iran<div><p class="abstract"><strong>BACKGROUND:</strong> Several studies have emphasized thrombosis associated with thrombocytopenia as a potentially fatal complication of heparin. A number of agents are used for this condition. As a new oral, reversible direct thrombin inhibitor, dabigatran has been approved for short-term thromboprophylaxis after elective hip and knee replacement surgery. We present a case of dabigatran administration in a patient with femoral fracture.</p> <p class="abstract"><strong>CASE REPORT:</strong> A 67-year-old woman referred to the orthopedic ward of Shariati Hospital (Isfahan, Iran) due to femoral fracture following an accident. Immediately after surgery, she was found to be suffering from deep vein thrombosis (DVT) in her lower extremity despite sufficient prophylaxis by enoxaparin. Laboratory data showed severe thrombocytopenia. Considering the clinical history, an initial diagnosis of heparin-induced thrombocytopenia was made. Doppler ultrasound confirmed the diagnosis. Heparin was thus replaced with dabigatran which increased platelet count to the normal range and improved DVT.</p> <p class="abstract"><strong>CONCLUSION:</strong> Dabigatran can be a life-saving treatment in heparin-induced thrombocytopenia. However, it is contraindicated in patients with renal dysfunction since it may cause potentially catastrophic results.</p> <p class="abstract">&nbsp;</p></div> <strong>Keywords:</strong> Heparin Induced Thrombocytopenia, Heparin, Enoxaparin, Dabigatranhttp://arya.mui.ac.ir/index.php/arya/article/view/428
spellingShingle Ahmad Mirdamadi
Dabigatran, a direct thrombin inhibitor, can be a life-saving treatment in heparin-induced thrombocytopenia
ARYA Atherosclerosis
title Dabigatran, a direct thrombin inhibitor, can be a life-saving treatment in heparin-induced thrombocytopenia
title_full Dabigatran, a direct thrombin inhibitor, can be a life-saving treatment in heparin-induced thrombocytopenia
title_fullStr Dabigatran, a direct thrombin inhibitor, can be a life-saving treatment in heparin-induced thrombocytopenia
title_full_unstemmed Dabigatran, a direct thrombin inhibitor, can be a life-saving treatment in heparin-induced thrombocytopenia
title_short Dabigatran, a direct thrombin inhibitor, can be a life-saving treatment in heparin-induced thrombocytopenia
title_sort dabigatran a direct thrombin inhibitor can be a life saving treatment in heparin induced thrombocytopenia
url http://arya.mui.ac.ir/index.php/arya/article/view/428
work_keys_str_mv AT ahmadmirdamadi dabigatranadirectthrombininhibitorcanbealifesavingtreatmentinheparininducedthrombocytopenia